Ετικέτες

Σάββατο 2 Δεκεμβρίου 2017

Scholar : intitle:Bioprinting - νέα αποτελέσματα

Bioprinting and Cellular Therapies for Type 1 Diabetes

J Dino, N Ashley, T Ibrahim - Trends in biotechnology, 2017
Abstract Type 1 diabetes mellitus is a chronic autoimmune disease that results from the
destruction of beta (β)-cells in the pancreatic islets, leading to loss of insulin production and
resultant hyperglycemia. Recent developments in stem cell biology have generated much
Google+ Facebook Twitter

Coaxial extrusion bioprinting of 3D microfibrous constructs with cell-favorable gelatin methacryloyl microenvironments

W Liu, Z Zhong, N Hu, Y Zhou, L Maggio, A Miri… - Biofabrication, 2017
Abstract Bioinks with shear-thinning/rapid solidification properties and strong mechanics are
usually needed for the bioprinting of three-dimensional (3D) cell-laden constructs. As such, it
remains challenging to generate soft constructs from bioinks at low concentrations that are
Google+ Facebook Twitter

Organ Bioprinting: Are We There Yet?

G Gao, Y Huang, AF Schilling, K Hubbell, X Cui - Advanced Healthcare Materials, 2017
Abstract About 15 years ago, bioprinting was coined as one of the ultimate solutions to
engineer vascularized tissues, which was impossible to accomplish using the conventional
tissue fabrication approaches. With the advances of 3D-printing technology during the past
Google+ Facebook Twitter

Dispensing-Based Bioprinting of Mechanically-Functional Hybrid Scaffolds with Vessel-like Channels for Tissue Engineering Applications–A Brief Review

S Naghieh, MD Sarker, M Izadifar, X Chen - Journal of the Mechanical Behavior of …, 2017
Abstract Over the past decades, significant progress has been achieved in the field of tissue
engineering (TE) to restore/repair damaged tissues or organs and, in this regard, scaffolds
made from biomaterials have played a critical role. Notably, recent advances in biomaterials
Google+ Facebook Twitter

Bioprinting technologies for disease modeling

A Vacacela - Biotechnology letters, 2017
Abstract There is a great need for the development of biomimetic human tissue models that
allow elucidation of the pathophysiological conditions involved in disease initiation and
progression. Conventional two-dimensional (2D) in vitro assays and animal models have
Google+ Facebook Twitter


Αυτή η Ειδοποίηση του Μελετητή Google σας προσφέρεται από τη Google

Ακύρωση ειδοποίησης
Δημιουργία λίστας των ειδοποιήσεών μου


Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Αναζήτηση αυτού του ιστολογίου